ANX bio popped briefly to 0.15 - company in negotiations with partner for marketing safer profiles of 2 drugs that pulled in 2.2 billion market share last year. One of the last below 0.20 that have potential major catalyst for multi-bagger.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.